Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Shikonin inhibits cancer cell cycling by targeting Cdc25s

Fig. 2

Shikonin inhibits Cdc25B irreversibly in vitro and induces ROS production in MCF-7 cells. a Activity of shikonin-treated Cdc25B after dialysis. b ROS production in MCF-7 and tsFT210 cells after treatment with shikonin. Data points represent fold change of three independent experiments. *P < 0.05; **P < 0.01 compared with the control group

Back to article page